Evidence map›Paper›PMID 21424341›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2012

Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Alice Nourissat, Isabelle Bairati, André Fortin, Michel Gélinas, Abdenour Nabid, François Brochet, Bernard Têtu, François Meyer

Registry-linked trialAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00169845 (Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00169845 phase3completednot on this map

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

TypeinterventionalSponsorLaval UniversityRan1994 to 2018Enrolled540ConditionsNeoplasmsArmsAlpha-Tocopherol and Beta-Carotene, Placebo
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Nutri-jelly may improve quality of life and decrease tube feeding demand in head and neck cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Trial
  4. Trial
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Frailty is an independent factor for health-related quality of life in patients with head and neck cancer receiving definitive concurrent chemoradiotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  10. Symptoms of oropharyngeal dysphagia, efficiency, and safety of swallowing in patients after treatment for head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Observational
  11. A European survey on the practice of nutritional interventions in head-neck cancer patients undergoing curative treatment with radio(chemo)therapy.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  12. Article
  13. Review
  14. Nutritional Issues in Head and Neck Cancer Patients.Healthcare (Basel, Switzerland) · 2020
    Review
  15. Nutritional status in patients with head and neck cancer undergoing radiotherapy: a longitudinal study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Observational
  16. Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  17. Article
  18. Article
  19. Understanding Cachexia in Head and Neck Cancer.Asia-Pacific journal of oncology nursing
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alice NourissatDepartment of Public Health, Saint-Etienne University Hospital, Cancer Institute of Loire, 108 bis avenue Albert Raimond, 42270 Saint Priest en Jarez, France. alice.nourissat@icloire.fr
Isabelle Bairati
André Fortin
Michel Gélinas
Abdenour Nabid
François Brochet
Bernard Têtu
François Meyer
Université Laval · CAInstitute Cancer De La Loire Lucien Neuwirth · FRUniversité de Montréal · CAUniversité de Sherbrooke · CAUniversité du Québec · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of the study was to identify factors associated with weight loss during radiotherapy (RT) in patients with stage I or II head and neck (HN) cancer.

methodsThis study was conducted as part of a phase III chemoprevention trial. A total of 540 patients were randomized. The patients were weighed before and after RT. Patients' characteristics, dietary intake, health-related quality of life (HRQOL), tumor characteristic, treatment characteristics, and acute adverse effects of RT were evaluated at baseline and during RT. Factors independently associated with weight loss during RT were identified using the multiple linear regression (P ≤ 0.05).

resultsThe mean weight loss during RT was 2.2 kg (standard deviation, 3.4). In bivariate analyses, the occurrence of adverse effects of RT and most of the HRQOL dimensions evaluated during RT were correlated with weight loss. In the multivariate analysis, eight factors were associated with a greater weight loss: all HN cancer sites other than the glottic larynx (P < 0.001), TNM stage II disease (P = 0.01), higher pre-RT body weight (P < 0.001), dysphagia before RT (P < 0.005), higher mucosa adverse effect of RT (P = 0.03), lower dietary energy intake during RT (P < 0.001), lower score of the digestive dimension on the Head and Neck Radiotherapy Questionnaire (P < 0.001) and a higher score of the constipation symptom on the EORTC QLQ-C30 during RT (P = 0.02).

conclusionsThe results underline the importance of maintaining energy intake in early stage HN cancer patients during RT and the importance of preventing and treating adverse effects.

Indexed as

Weight Lossalpha-Tocopherolbeta CaroteneBody WeightCarcinoma, Squamous CellCausalityChemopreventionChemoradiotherapyComorbidityDouble-Blind MethodEatingFemaleHead and Neck NeoplasmsHumansMaleMiddle Agedalpha-Tocopherolbeta Carotene

Identifiers

PMID21424341
OpenAlexW2051514237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.